Health> Vol.5 No.11, November 2013

Suppressed response to hormonal contraceptives in women of Khairpur, Sindh, Pakistan

DownloadDownload as PDF (Size:231KB)  HTML    PP. 1848-1852  

ABSTRACT

Objective: Contraception has gained gradual popularity in many parts of the developing world including Pakistan. Despite this increase in acceptance, the birth rate remains high. Failure of contraception has been reported in the literature, which made us aim to conduct this study. The efficiency of hormonal contraceptives in the study area was assessed and this is the first report from Pakistan. Methods: A total of 200 women (aged 20-30 and 31-40 years; n = 100 each) with minimum consistent use of hormonal contraceptives in the form of pills (Combined oral contraceptives) for 12 months were enrolled in this study. Blood samples were collected from women of each age group and corresponding control groups (n = 100) from local hospitals and reproductive health service center. Serum levels of the fertility hormones viz leutinizing and follicle stimulating hormones were measured through ELISA technique. Results: Our data revealed that over all in the both age groups, 72% women had normal, 16% increased and 12% showed decreased levels of leutinizing hormone (p > 0.05) and 67% women showed normal, 33% showed decreased and no increased levels were found for follicle stimulating hormone (p > 0.05). No age-wise significant difference in response was observed among both the age groups tested. Conclusion: Statistically insignificant difference in serum leutinizing hormone and follicle stimulating hormone seen among both the age groups of hormonal contraceptive users and control group indicates less effective hormonal contraception response in the study area.

Cite this paper

Kazi, Y. , Saleem, S. and Kazi, N. (2013) Suppressed response to hormonal contraceptives in women of Khairpur, Sindh, Pakistan. Health, 5, 1848-1852. doi: 10.4236/health.2013.511248.

References

[1] Huezo, C.M. (1998) Current reversible contraceptive methods: A global perspective. International Journal of Gynecology & Obstetrics, 62, S3-S15.
http://dx.doi.org/10.1016/S0020-7292(98)00084-8
[2] Vazque, H.L., Tellez, M.J. and Hiks, G.J. (2000) Clinical and metabolic effects of oral contraceptives. Obstetrics & Gynecology, 68, 64-69.
[3] Jung-Hoffman, C., Heidt, F. and Kuhl, H. (1988) Effect of two oral contraceptives containing 30 μg ethinyestradiol and 75 μg gestodene or 150 μg desogestrel upon various parameters. Contraception, 38, 593-603.
http://dx.doi.org/10.1016/0010-7824(88)90044-3
[4] Hatcher, R.A. and Guillebaud, M.A. (1998) The pill: combined oral contraceptives. In: Hatcher, R.A., Trussell, J., Stewart, F., et al., Eds., Contraceptive Technology, Ardent Media, New York, 405-466.
[5] Finer, L.B. and Henshaw, S.K. (2006) Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspectives on Sexual and Reproductive Health, 38, 90-96. http://dx.doi.org/10.1363/3809006
[6] Mosher, W.D., Martinez, G.M., Chandra, A., Abma, J.C., Wilson, S.J., Hyattsville, M.D., National Center for Health Statistics (2004) Use of contraception and use of family planning services in the United States: 1982-2002. Advance Data from Vital and Health Statistics, 350.
[7] Bajos, N., Leridon, H. and Job Spira, N. (2004) Contraception and abortion in France in the 2000s. The COCON survey. Population, 3-4, 347-356.
http://dx.doi.org/10.3917/pope.403.0347
[8] Population reference bureau 2011 world population data sheet. www.prb.org
[9] Population welfare department government of Sindh 2011.
http://www.pwdsindh.gov.pk/khairpur
[10] Robinstein, L., Moguilevsky, F.M. and Leiderman, S. (1978) The effect of oral contraceptives on the gonadotropin response to LHRH. Obstetrics & Gynecology, 52, 571-574.
[11] Goldzier, J.W., Kleber, J.W., Moses, L.E. and Rathmacher, R.P. (1970) A cross-sectional study of plasma FSH and LH levels in women using sequential, combination or injectable steroid contraceptives over long periods of time. Contraception, 2, 225-248.
http://dx.doi.org/10.1016/0010-7824(70)90035-1
[12] Slaats, E.H., Kennedy, J.C., de Vries, R.K. and Schoemaker, J. (1993) Pulsatile leutinizing hormone patterns in long term oral contraceptives users. The Journal of Clinical Endocrinology & Metabolism, 77, 2420-2426.
[13] Tafurt, C.A., Sobrevilla, L.A. and De Estrada, R. (1980) Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids and sex hormone-binding globulin. Fertility and Sterility, 33, 261-266.
[14] Holt, V.L., Scholes, D., Wicklund, K.G., Cushing-Haugen, K.L. and Daling, J.R. (2005) Body mass index, weight, and oral contraceptive failure risk. Obstetrics & Gynecology, 105, 46-52.
http://dx.doi.org/10.1097/01.AOG.0000149155.11912.52
[15] (2012) Faculty of sexual and reproductive healthcare drug interactions with hormonal contraceptive. Registered in England No. 2804213 and Charity No. 1019969.
[16] Toh, S., Mitchell, A.A., Anderka, M., de Jong-van den Berg, L.T. and Hernández-Díaz, S. (2011) Antibiotics and oral contraceptive failure—A case-crossover study. Contraception, 83, 418-425.
http://dx.doi.org/10.1016/j.contraception.2010.08.020
[17] Wang, H., Bos, J.H. and de Jong-van den Berg, L.T. (2012) Co-prescription of antiepileptic drugs and contraceptives. Contraception, 85, 28-31.
http://dx.doi.org/10.1016/j.contraception.2011.04.017

comments powered by Disqus

Copyright © 2014 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.